Furthermore, when comparing microbiota functional composition of BRAF-mutated versus wild-type counterpart a decrease in microbiota-associated metabolic functions was predicted (Figs. 4 and 7), thus confirming the capability of gut microbes to affect tumor through their metabolic functions, beside their impact on host immune and inflammatory responses [44]. This evidence concerns the gene BRAF and neoplasm.